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here that Ser-113 in MARCKS is a substrate for p42 MAPK,  Abstract It is demonstrated here that p42 MAPKinase (p42 
MAPK) phosphorylates the Myristoylated Alanine-Rich C- but that under conditions of p42 MAPK aclivation there is no 
Kinase Sobstrate (MARCKS) at Ser-ll3. In permeabilised acute increase in Ser- l l3  phosphorylat ion. 
Swiss 3T3 cells activation of protein kinase C (PKC) leads to p42 
MAPK activation, but only the protein kinase C sites in 2. Materials and methods 
MARCKS become phosphorylated and not Ser-ll3. The 
mitogen platelet-derived growth factor (PDGF) elicits the same 2.1. Materials 
response. These results demonstrate that while Ser-ll3 is a Trypsin was purchased from Worthington. [¥-:~P]ATP and Hyper- 
substrate for p42 MAPK in vitro and can be phosphorylated in film were from Amersham and streptolysin-O from Wellcome. Cellu- 
vivo as shown by Taniguchi et al. 1(19941 J. Biol. Chem. 269, lose thin-layer chromatography plates were supplied by Kodak and 
foetal call" serum was from Gibco Bethesda Research Laboratories. 18299-183021, its phosphorylatinn is not subject to acute Mutagenesis was performed using the Chameleon double-stranded, 
regulation by p42 MAPK in Swiss 3T3 cells, site-directed mutagenesis kit from Promega. All other biochemical 
reagents were from Sigma. A polyclonal antiserum that detects p42 
Key word~'." p42MAPKinase;  MARCKS;  Protein kinase C; MAPK was raised in rabbits against he peptide ITVEEALAHPY- 
Phosphorylat ion LEQYYDPTFDEPV. 
2.2. MA RCKS phosphorylation i  permeabilised Swiss 3 T3 
Swiss 3T3 cells were cultured as described previously [7]. A 15 cm 
dish of quiescent Swiss 3T3 cells was washed three times with pre- 
1. Introduction warmed phosphate-buffered saline (PBS) and incubated with a freshly 
prepared mixture of 1 ml streptolysin-O (0.036 IU/ml) and 4 ml pre- 
The Myristoylated Alanine-Rich . . . .  C-Kinase Substrate warmed permeabilisation buffer (6.25 mM MgC12, 10 ~tM ATP, 12.5 
(MARCKS)  is a well characterised protein kinase C (PKC) mM PIPES pH 7.4, 150 mM KC1, 1.25 mM EGTA, 0.75 mM CaCI.,, 
substrate that is a marker for PKC activation in vivo (reviews 37.5 mM NaC1, 20 ~tM leupeptin, 1.5 p.M aprotinin, 1 ~tM microcys- 
tin) for 3 min. Subsequently [7-:~2P]ATP (10 ~tCi) was added and the 
[2,3]). Phosphorylat ion of MARCKS by PKC has been shown cells were stimulated with TPA (400 riM) or PDGF (50 ng/ml) for a 
to interrupt its interaction with calmodulin and actin [4] and further 10 min. The cells were scraped into an Eppendorf tube and 
thereby displaces MARCKS from the cytoskeleton. Consis- homogenized with 10 strokes through a syringe fitted with a 25 gauge 
tent with these PKC-dependent phosphorylat ions control l ing needle. Extracts were heated for 10 min at 95°C, incubated on ice for 
10 min and centrifuged for a further 10 min at 12000 rpm in a bench- 
such functions in vivo, it has been established that MARCKS top microfuge. The heat-stable MARCKS protein was precipitated 
is displaced from the cytoskeleton on PKC activation [5]. with trichloroacetic acid (10% final concentration) for 4 h at room 
Recent studies have indicated that other kinases are in- temperature. After centrifugation the pellet was resuspended in 
volved in regulating MARCKS phosphorylat ion. In vitro, 1× Laemmli sample buffer [8] and loaded onto a 10% SDS-PAGE 
gel. The Coomassie-stainable and of 80 kDa was excised and sub- 
the PKC-related kinase 1 (PRK1) can phosphorylate jected to 2-dimensional peptide mapping. 
MARCKS on serines 152, 156 and 163, the same residues 
targeted by PKC itself [6]. This indicates that MARCKS 2.3. Protein pur![ieation 
phosphorylat ion at these sites is not an exclusive monitor  of Purification of the GST-MARCKS fusion protein was as described 
earlier [9]. Recombinant p42 MAPK was purified according to Stokoe 
PKC activation. Additionally, it has been shown that et al. [10] and recombinant protein kinase C was purified from Sf9 
MARCKS isolated from bovine brain is phosphorylated on cells according to Stabel et al. [11]. 
sites not targeted by PKC or PRK [1]. These sites are serine or 
threonine residues followed by a proline, suggesting the in- 2.4. MARCKS pho~phorylation by p42 MAPK in vitro 
volvement of proline-directed kinases. Active MEK IMAPK or ERK kinase) protein was immunoprecipi- 
tated from one 1"3 cm dish-of confluent Swiss 3T3 cells that were 
One of the downstream targets of PKC is the p42 MAPKi -  stimulated with 250 nM TPA for 10 min. The cells were washed twice 
nase (p42 MAPK)  which phosphorylates Ser/Thr residues ur- in ice-cold PBS and scraped into buffer A (50 mM Tris-HCl pH 7.5, 
rounded by two proline residues. Since many growth factors 100 mM NaC1, 5 mM EDTA, 100 gM Na:~V()~, 50 mM NaF, 1% 
and the PKC activator 12-tetradecanoyl phorbol-13-acetate Triton X-100, 50 gg/ml PMSF, 10 mM benzamidine, 125 gg/ml apro- 
(TPA) induce PKC as well as MAPK activation and result tinin, 250 ~tg/ml leupeptin). MEK antiserum (12.5 ~tl) and 70 ~tl ofa S. 
aureus cell suspension 1:1 slurry in PBS were added and the extracts 
in phosphorylat ion of MARCKS,  it has been important to were incubated for 5 h at 4°C. After immunoprecipitation of active 
establish whether p42 MAPK itself in any way accounts for MEK protein, the antibody complex was washed three times in buffer 
the control of MARCKS phosphorylat ion. It is demonstrated A (with 150 mM NaCI). The protein was eluted from the antibody 
complex in 150 gl PBS containing the peptide antigen (2 mg/ml). 
Active MEK (20 lal) in PBS (or alternatively 0.3 gg of active 
*Corresponding author. Fax: (44) (171) 269 3092. MEK1 S117E $221E [12]) were incubated with 0.3 ~tg recombinant 
p42 MAPK, 10 ~tg of either GST-MARCKS or GST in the presence 
**Present address: The Salk Institute, PO BOX 85800, San Diego, of 1 gCi [y-:~2P]ATP in buffer B (25 mM HEPES pH 7.5, 10 mM 
CA 92186-5800, USA. pNPP, 0.1 mM EDTA, 10 mM MgC1,) for 30 min at 30°C. The 
0014-5793/96/$12.00 (~3~ 1996 Federation of European Biochemical Societies. All rights reserxed. 
PII $00 I 4 -579  3(96 )0099 1 -X 
2 D.C. Sch6nwaBer t al./FEBS Letters 395 (1996) 1 5 
samples were loaded onto a 10% SDS-PAGE gel, dried down and 
autoradiographed. [ 
2.5. Site-directed mutagenesis 
Mutagenesis of Ser-113 to Ala was performed with the Chameleon 
kit from Stratagene according to the manufacturer's in tructions. To 
introduce a two base pair exchange into MARCKS pGEX 2T we used 
the following oligonucleotide GGCCGAGCCCGCCGAGCCGGC- 
CTCCCCGGCCGCCGAGGC-. The second oligonucleotide - GAG- 
CCCGCCGAGCCCAGCGCGCCGGCCGCCGAGGCCGAG - was 
used for selection of mutated ouble stranded plasmid and was de- 
signed to destroy a KpnI restriction site in the plasmid sequence of 
pGEX 2T. 
2.6. Other procedures 
Protein determination f GST-MARCKS was carried out according 
to the method of Bradford [13]. Other proteins were measured with 
the BCA protein assay reagent (Pierce). SDS-PAGE was performed 
according to [8]. Two-dimensional peptide mapping was performed as >~ 
described in [61 .
3. Results and discussion 
~:~ ~ origin 
3.1. p42 MAPK phosphorylates MARCKS in vitro ~ 
The 80 kDa MARCKS protein is a well described substrate 
for PKC and the related PRK family [2,6]. As recently re- electrophoresis origin 
ported by Taniguchi et al. [1], MARCKS protein isolated 
from bovine brain was found to be phosphorylated not only Fig. 2. Two-dimensional analysis of MARCKS phosphopeptides. 
on the three serine residues targeted by PKC and PRK (Ser- GST-MARCKS was phosphorylated by p42 MAPK, the proteins 
152, Ser-156, Ser-163) but also on six so far unknown sites, were separated by SDS-PAGE and the 110 kDa full length GST- 
MARCKS was excised and digested with trypsin. The resulting pep- 
one of which corresponds to the p42/p44 MAPK phosphor- tides were separated on a cellulose thin-layer chromatography plate 
ylation motif P-X-S/T-P. by electrophoresis for 20 min at 50 mA (lst dimension) and then 
In order to assess if MARCKS is a substrate for p42 ascending chromatography (2nd dimension) for 4 h until the buffer 
MAPK, activated recombinant MAPK protein was incubated front had reached the top of the plate. The plate was then dried 
and autoradiographed. with GST-MARCKS in the presence of [~'-32p]ATP. Two 
phosphorylated bands (Fig. 1, lane 1) migrating as 110 and 
70 kDa proteins were obtained. These represent the full-length 
fusion protein of MARCKS and an N-terminal fragment that GST moiety of the fusion protein is not phosphorylated (Fig. 
is generated by proteolysis during expression in bacteria. The 1, lane 5-7). 
To determine whether MAPK phosphorylates one of the 
proline-directed residues identified in vivo, full-length GST- 
MARCKS was isolated from an SDS-PAGE gel, digested 
1 2 3 4 5 6 7 with trypsin and subjected to 2-dimensional electrophoresis. 
Fig. 2 shows that p42 MAPK phosphorylates a single tryptic 
- -  200 peptide that migrates quite differently from the four peptides 
targeted by PKC all of which move away from the origin in 
GST-MARCKS ~ - -  97 the first dimension (compare Fig. 5C). 
69 
3.2. p42 MAPK phosphorylates MARCKS at Ser-ll3 46 Partial sequencing of the tryptic peptide indicated that it is 
the peptide I°2-EAAEAEPAEPSSPAAEAEGASASSTSSPK- 
a30 which is phosphorylated by p42 MAPK (data not shown). 
This peptide contains two of the six residues identified to be 
] - -  30 phosphorylated in vivo [1], including one (Ser-ll3) that 
matches the MAPK phosphorylation motif. Site-directed mu- 
l tagenesis of Ser-113 generated a protein that was phosphory- ] 22 lated poorly by MAPK compared to the wild-type protein 
(Fig. 3A). This residual phosphorylation was contributed by 
low stoichiometry phosphorylation sites other than Ser-113 
Fig. 1. Phosphorylation f GST-MARCKS by p42 MAPK. Recom- and was not detectable after separation of the phosphorylated 
binant p42 MAPK protein was activated by MEK which was im- peptides by electrophoresis and thin-layer chromatography 
munoprecipitated from TPA-stimulated Swiss 3T3 cells. Active p42 (Fig. 3B). 
MAPK phosphorylates GST-MARCKS (lane 1) but not the GST 
moiety itself (lane 5). Non-activated p42 MAPK or active MEK do 
3.3. p42 MAPK does not phosphorylate MARCKS in not phosphorylate GST-MARCKS (lanes 2,3) or GST (lanes 6,7). A 
control phosphorylation with active MEK and p42 but no substrate permeabilised Swiss 3 T3 cells 
protein is shown in lane 4. In order to assess if MAPK regulates the phosphorylation 
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Fig. 3. (A) p42 MAPK can phosphorylate MARCKS wt efficiently but not MARCKS S113A. Recombinant p42 MAPK activated by MEK 
SII7E $221E phosphorylates GST-MARCKS wt (lanes 1,3) but to a far lesser extent he mutated GST-MARCKS S113A (lanes 2,4). Lane 5 
shows a control reaction without MARCKS substrate protein. (B) Equal amounts of GST-MARCKS wt (1) and GST-MARCKS S113A (ll) 
protein shown in lanes 3 and 4 (panel A) were excised from the SDS-PAGE gel, digested with trypsin and subjected to 2-dimensional peptide 
mapping and autoradiographed, as described in Fig. 2. 
of MARCKS at Ser-113 acutely, we used permeabil ised Swiss kinase stays in the appropriate compartment  relative to its 
3T3 cells that were labelled with [y-32P]ATP. Fig. 4 shows that potential substrate (i.e. MARCKS) .  
phorbol  ester treatment of permeabil ised cells can activate p42 Permeabilised Swiss 3T3 cells were stimulated by TPA or 
MAPK in this system. Furthermore,  p42 MAPK remains in PDGF in order to activate p42 MAPK.  MARCKS protein 
the cytosol of the cells after activation. This means the active was purified, digested with trypsin and peptides subjected to 
electrophoresis and thin-layer chromatography.  The resulting 
Streptolysin-O[min.l 5 3 3 3 phosphopeptide maps were compared to phosphopeptide 
TPAlmin.] 0 2 5 8 maps of MARCKS after in vitro phosphorylat ion by PKC 
(Fig. 5A D). Analysis of the labelled peptides shows that 
SN P SN P SN P SN P PDGF and TPA treatment do not induce acute phosphoryla- 
tion of MARCKS on Ser- l l3  (compare Fig. 2t. 
69 3.4. Discussion 
~ It i.s established that p42MAPK can phosphorylate residue 
~"  ~ Ser- l l3  in MARCKS.  This is consistent with the known spec- 
~ ° - -46  ificity of this protein kinase. Although this serine in 
p42 MAPK active ~ '  .... "~" ~ MARCKS is known to be phosphorylated in vivo in bovine 
inactive ~ ~ ~ "-- ~" brain, it is shown here that acute activation of p42 MAPK in 
~ : ~ . f ~  ~ permeabilised Swiss 3T3 cells does not alter Ser-113 phos- 
phorylat ion or that of other ~non-PKC" sites. This distinction 
Fig. 4. TPA activates MAPK in permeabilised Swiss 3T3. Swiss 3T3 could be explained by tissue-specific differences in MAPK 
cells were permeabilised with streptolysin-O and then treated for 2, function, by the fact that Ser- l l3  might be fully phosphory- 
5 or 8 min with TPA as described in Section 2. Subsequently cells lated in quiescent Swiss 3T3 cells or by the action of a brain- 
were centrifuged for 10 min at 12000 rpm. Pellets (P) were resus- 
pended in 1 x sample buffer. Supernatants (SN) were trichloroacetic specifc proline-directed kinase. 
acid-precipitated and resuspended in 1 xsample buffer and were It is concluded that phosphorylat ion of MARCKS in tour- 
loaded on a 10% SDS-PAGE gel. In non-stimulated cells the major- ine fibroblasts is not subject to direct, acute control by p42 
ity of p42 MAPK is in the inactive, faster migrating form (as indi- MAPK.  cated), whereas 2, 5 or 8 min treatment with TPA shifts almost all 
the enzyme to the active, slower migrating form. A similar shift can 
be observed for p44 MAPK. Acknowledgements: We are grateful to Dr. J. Hsuan for preliminary 
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Fig. 5. Comparison of MARCKS phosphorylation i Swiss 3T3 cells after stimulation by TPA or PDGF and in vitro phosphorylation by 
PKC. Swiss 3T3 cells were permeabilised and stimulated by PDGF (A) or TPA (B) in the presence of D'-a2P]ATP. MARCKS was isolated by 
SDS-PAGE, digested and subjected to 2-dimensional peptide mapping. The resulting phosphopeptide maps were compared to maps of GST- 
MARCKS protein phosphorylated by PKC in vitro (C). A diagram of the major tryptic MARCKS phosphopeptides characteristic for MAPK 
phosphorylation (peptide 1, EAAEAEPAEPS*SPAAEAEGASASSTSSPK; compare Fig. 2) or PKC phosphorylation (peptides 2-5: peptide 2, 
LSGFS*FK; peptide 3, RFS*FK and/or FS*FKK; peptide 4, LSGFS*FKK, peptide 5, S*FK) is shown in (D). 
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